These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7947993)

  • 1. Distribution of immunoreactive malondialdehyde-modified low-density lipoprotein in human serum.
    Kotani K; Maekawa M; Kanno T; Kondo A; Toda N; Manabe M
    Biochim Biophys Acta; 1994 Nov; 1215(1-2):121-5. PubMed ID: 7947993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of malondialdehyde-modified LDL(MDA-LDL) and its potential usefulness].
    Kotani K; Kondo A; Manabe M; Maekawa M; Kanno T
    Rinsho Byori; 1997 Jan; 45(1):47-54. PubMed ID: 9022342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gold nanoparticle-antibody conjugates for specific extraction and subsequent analysis by liquid chromatography-tandem mass spectrometry of malondialdehyde-modified low density lipoprotein as biomarker for cardiovascular risk.
    Haller E; Lindner W; Lämmerhofer M
    Anal Chim Acta; 2015 Feb; 857():53-63. PubMed ID: 25604820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of fibrate treatment on malondialdehyde-modified LDL concentration.
    Kondo A; Morita H; Nakamura H; Kotani K; Kobori K; Ito S; Manabe M; Saito K; Kanno T; Maekawa M
    Clin Chim Acta; 2004 Jan; 339(1-2):97-103. PubMed ID: 14687899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of malondialdehyde-modified low density lipoproteins. Studies with monoclonal antibodies.
    Gonen B; Fallon JJ; Baker SA
    Atherosclerosis; 1987 Jun; 65(3):265-72. PubMed ID: 2441716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis.
    Cvetkovic JT; Wållberg-Jonsson S; Ahmed E; Rantapää-Dahlqvist S; Lefvert AK
    Rheumatology (Oxford); 2002 Sep; 41(9):988-95. PubMed ID: 12209031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation and characterization of IgG monoclonal antibodies specific for malondialdehyde.
    Choi JW; Kim DJ; Rhim JH; Chung JH; Chung HK
    Hybrid Hybridomics; 2003 Aug; 22(4):259-62. PubMed ID: 14511571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of autoantibodies against oxidatively modified low-density lipoprotein in essential hypertension: a biochemical signature of an enhanced in vivo low-density lipoprotein oxidation.
    Maggi E; Marchesi E; Ravetta V; Martignoni A; Finardi G; Bellomo G
    J Hypertens; 1995 Jan; 13(1):129-38. PubMed ID: 7759843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of capture assays for different modifications of human low-density lipoprotein.
    Virella G; Derrick MB; Pate V; Chassereau C; Thorpe SR; Lopes-Virella MF
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):68-75. PubMed ID: 15642987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease.
    Holvoet P; Perez G; Zhao Z; Brouwers E; Bernar H; Collen D
    J Clin Invest; 1995 Jun; 95(6):2611-9. PubMed ID: 7769103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a novel ELISA for measurement of MDA-LDL in human plasma.
    Bevan RJ; Durand MF; Hickenbotham PT; Kitas GD; Patel PR; Podmore ID; Griffiths HR; Waller HL; Lunec J
    Free Radic Biol Med; 2003 Sep; 35(5):517-27. PubMed ID: 12927601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological detection of low-density lipoproteins modified by malondialdehyde in vitro or in vivo.
    Salmon S; Maziere C; Theron L; Beucler I; Ayrault-Jarrier M; Goldstein S; Polonovski J
    Biochim Biophys Acta; 1987 Aug; 920(3):215-20. PubMed ID: 3111542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
    Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
    Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between high-density lipoprotein-cholesterol and malondialdehyde-modified low-density lipoprotein concentrations.
    Kondo A; Li J; Manabe M; Saito K; Kanno T; Maekawa M
    J Atheroscler Thromb; 2003; 10(2):72-8. PubMed ID: 12740480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
    Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
    Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific recognition of malondialdehyde and malondialdehyde acetaldehyde adducts on oxidized LDL and apoptotic cells by complement anaphylatoxin C3a.
    Veneskoski M; Turunen SP; Kummu O; Nissinen A; Rannikko S; Levonen AL; Hörkkö S
    Free Radic Biol Med; 2011 Aug; 51(4):834-43. PubMed ID: 21683785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein.
    Valentinova NV; Gu ZW; Yang M; Yanushevskaya EV; Antonov IV; Guyton JR; Smith CV; Gotto AM; Yang CY
    Biol Chem Hoppe Seyler; 1994 Oct; 375(10):651-8. PubMed ID: 7534086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production and characterization of monoclonal antibodies to oxidized LDL.
    Choi K; Lee HS; Chung HK
    Exp Mol Med; 1998 Mar; 30(1):41-5. PubMed ID: 9873821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.